Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — December 2022

Genmab — December 2022

Planlagt Fastgjort Låst Flyttet Genmab
668 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • L Offline
    L Offline
    lahn1
    wrote on sidst redigeret af
    #101

    Ja dejligt positivt skriv af Mygind, tak

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #102

      Godmorgen 🙂

      1 Reply Last reply
      0
      • D Offline
        D Offline
        Doublo
        wrote on sidst redigeret af
        #103

        God morgen jeg kan ikke åbne oversigten over short positioner på finanstilsynets hjemmeside, måske fordi jeg er i udlandet? der har været 0,5 på Genmab ville bare se, om de har solgt.

        1 Reply Last reply
        0
        • D Offline
          D Offline
          Doublo
          wrote on sidst redigeret af
          #104

          God morgen Helge 😄 du er tidligt oppe, jeg snyder der hvor jeg opholder mig er klokken 2 timer mere.

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Stroka
            wrote on sidst redigeret af
            #105

            God morgen 🙂

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #106

              I see that the R&D Update is in the middle of the -european- night next week 😞 Will we get a replay? We need a volunteer to stay up and make a summary... https://ir.genmab.com/events-and-presentations#content

              1 Reply Last reply
              0
              • B Offline
                B Offline
                bibob
                wrote on sidst redigeret af
                #107

                E.L. I vote on you. 😉

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #108

                  that wasn't exactly what i had in mind lol

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #109

                    Julerally på aktiemarkedet? På de sociale aktiemedier og finansmedier bliver der lige nu gættet på livet løs om, hvorvidt vi kommer til at se et julerally i år. Hvad tror Helge Larsen? Og hvorfor? Derudover kommer han ind på Equinor, laksesektoren, Anavex og Genmab. https://www.proinvestor.com/boards/108513

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #110

                      Hej Dublo, Jeg står op før kl. 5, men starter normalt først på Proinvestor kl. 6. Nyd din ferie, hvor end du er. 🙂

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        GeorgeBest
                        wrote on sidst redigeret af
                        #111

                        ph I/II epcoritamab + R-DHAX transplant-eligible r/r DLBCL (n=29)

                        • most common AEs hematologic, CRS (mild)
                        • pts ➡️ ASCT ORR 100%
                        • non-ASCT pts (mostly pt choice) ORR 64%
                          fascinating data for the combination https://twitter.com/chanyooncheah/status/1600890760546914304?s=61&t=kTAfbfq899c3srDizGwYoA
                        1 Reply Last reply
                        0
                        • D Offline
                          D Offline
                          Doublo
                          wrote on sidst redigeret af
                          #112

                          God morgen fra Tyrkiet klart du må starte før kl. 5 Helge,
                          eller kunne du slet ikke nå det du når.

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #113

                            Godmorgen 🙂

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Stroka
                              wrote on sidst redigeret af
                              #114

                              God morgen 🙂

                              1 Reply Last reply
                              0
                              • G Offline
                                G Offline
                                GeorgeBest
                                wrote on sidst redigeret af
                                #115

                                #ASH22 Talquetamab, a GPRC5D x CD3 Bispecific Antibody, in Patients with RRMM. At 0.4 mg/kg/week: ORR 73%, median PFS 7.5 months. https://twitter.com/transplant_doc/status/1600722580859949056?s=61&t=xzQrHseV4vIwvZlzzdG0vA

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #116

                                  Genmab rider på en bølge af succes

                                  David Mygind
                                  Fredag 09. december https://ugebrev.dk/life-science/genmab-rider-paa-en-boelge-af-succes/

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #117

                                    "Genmab: Præsenterede torsdag data for Gen1042 der var bedre end forventet" https://www.jyskebank.dk/finansnyt/morgennyt/2f4f3c0d-af87-4ffd-94d0-47e163666bb1 -I still can't find anything about it; we'll probably have to wait for the R&D day

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #118

                                      Nsclc er en svær øvelse https://www.ipsen.com/websites/Ipsen_Online/wp-content/uploads/2022/12/08195320/Ipsen-Contact-Press-Release-12-2022-1.pdf

                                      1 Reply Last reply
                                      0
                                      • nohopeN Offline
                                        nohopeN Offline
                                        nohope
                                        wrote on sidst redigeret af
                                        #119

                                        The problem with Mygind is that according to him then is the sky over Genmab is not just always blue, it is luminiscent.

                                        1 Reply Last reply
                                        0
                                        • G Offline
                                          G Offline
                                          GeorgeBest
                                          wrote on sidst redigeret af
                                          #120

                                          Well, the sky has been quite blue the last 10 years. Why would you make it grey then?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper